Target intelligence / Profile preview

Nipah virus RNA-directed RNA polymerase (L protein) (NiV RdRp or NiV L protein)

Target
NiV RdRp or NiV L protein
Molecular classification
Enzyme, RNA-dependent RNA polymerase, Viral protein, The largest viral protein with a molecular weight of approximately 250 kDa, Comprises five functional domains: the RdRp domain (N-terminus), the polyribonucleotidyltransferase (PRNTase) domain, a connector domain, a methyltransferase (MTase) domain, and a C-terminal domain
01

Overview

Nipah virus RNA-directed RNA polymerase (L protein) is the catalytic enzyme complex responsible for replicating the viral genome and synthesizing viral mRNA in Nipah virus, a highly pathogenic bat-borne zoonotic RNA virus capable of human-to-human transmission. The ~250 kDa L protein assembles with a phosphoprotein (P) cofactor to form a functional polymerase complex that catalyzes both genome replication and transcription through its multiple enzymatic domains, including the RdRp domain, PRNTase domain for capping, and methyltransferase domain. Recent structural studies using cryo-electron microscopy have revealed the molecular architecture of this polymerase complex in multiple functional states, including apo enzyme and RNA-bound elongation states, providing unprecedented insight into the mechanisms of viral RNA synthesis. The polymerase is considered an attractive therapeutic target for antiviral drug development, and the detailed structural information now available is facilitating rational design of inhibitors that could disrupt L-P interactions or block the catalytic active site. Understanding the structural basis of NiV polymerase function is critical for developing effective treatments against a virus with significant pandemic potential.

Other names
RNA-dependent RNA polymerase (RdRp)Large protein (L)L-P complex (when referring to the functional polymerase complex with the phosphoprotein)
02

Mechanism of action

Inhibition strategies being explored include: Direct inhibition of the RdRp catalytic domain; Disruption of the L-P protein interactions, which are essential for polymerase activity; Targeting the zinc-binding sites in the PRNTase domain, which are essential for polymerase function; Targeting the NTP entry channel. Rational drug design is being facilitated by recent cryo-electron microscopy (cryo-EM) structures that reveal the polymerase architecture in both apo and RNA-bound states.

03

Biological functions

Viral genome replication: The L protein's RdRp domain catalyzes replication of the viral genomic RNAmRNA transcription: The polymerase mediates viral mRNA synthesismRNA capping: The PRNTase and MTase domains complete the capping process, methylating the cap structure at the 2'-O and N7 positions to aid in evading host innate immunityRNA synthesis initiation and elongation: The polymerase complex orchestrates both de novo initiation and elongation of RNA synthesis through conformational changes in its priming loop
04

Disease associations

Nipah virus is a bat-borne, zoonotic RNA virus that is highly pathogenic in humans, frequently causing zoonotic outbreaks with potential for human-to-human transmission
05

Safety considerations

No safety concerns from previous drug targeting are documented, as no approved antivirals against this target currently exist.The structural flexibility of certain polymerase domains (particularly the C-terminal regions and priming loop) presents challenges for achieving selectivity and preventing emergence of drug-resistant viral variants.
06

Interacting drugs

No specific approved drugs targeting the Nipah virus polymerase are mentioned in the search results.

1 more in the full profile.

07

Biomarkers

No specific biomarkers for patient selection or efficacy monitoring are detailed in the available search results.

Beyond the preview

Go deeper on Nipah virus RNA-directed RNA polymerase (L protein) (NiV RdRp or NiV L protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nipah virus RNA-directed RNA polymerase (L protein) (NiV RdRp or NiV L protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call